allele_iedb stringclasses 95
values | allele stringclasses 95
values | allele_compact stringclasses 95
values | peptide stringlengths 7 15 | peptide_length int64 7 15 | measurement_type stringclasses 2
values | measurement_value float64 0 14.3M | measurement_units stringclasses 1
value | assay_method stringclasses 6
values | assay_response stringclasses 2
values | pubmed_id float64 7.51M 39.2M ⌀ | parent_protein stringlengths 3 188 ⌀ | protein_accession stringlengths 6 14 | source_organism stringclasses 991
values | source_version stringclasses 2
values | flagged bool 2
classes | self_templated bool 2
classes | has_structures bool 1
class | num_pdbs int64 25 25 | I_sc_best float64 -102.03 -37.97 | I_sc_mean float64 -93.88 60.2 | reweighted_sc_best float64 -733.37 -37.85 | reweighted_sc_mean float64 -705.21 18.9 | total_score_best float64 -623.72 1.04 | total_score_mean float64 -607.3 44 | pdb_dir stringlengths 33 41 | pep_sc_best float64 -42.79 82.3 | pep_sc_mean float64 -39.15 122 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLA-B_35_03 | B*35:03 | B3503 | HPNIEEVAL | 9 | IC50 | 6.8 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,508,927 | Genome polyprotein | ACE82359.1 | hepatitis C virus genotype 1a | v1 | false | false | true | 25 | -73.162 | -63.28 | -683.34 | -648.52404 | -585.842 | -565.7758 | structures/B3503/H/HPNIEEVAL.silent | -28.359 | -19.46816 |
HLA-B_35_03 | B*35:03 | B3503 | SPGDLQTLAL | 10 | IC50 | 16,115 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,539,795 | Insulin-1 | NP_032412.3 | Mus musculus | v1 | false | false | true | 25 | -62.861 | -50.62504 | -645.083 | -586.55464 | -568.58 | -529.36148 | structures/B3503/S/SPGDLQTLAL.silent | -14.74 | -6.56832 |
HLA-B_42_01 | B*42:01 | B4201 | SPGDLQTLAL | 10 | IC50 | 35 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,539,795 | Insulin-1 | NP_032412.3 | Mus musculus | v1 | false | false | true | 25 | -67.506 | -55.73892 | -661.741 | -616.11124 | -575.301 | -549.80556 | structures/B4201/S/SPGDLQTLAL.silent | -23.817 | -10.56668 |
HLA-B_42_01 | B*42:01 | B4201 | GPGAGSLQPLAL | 12 | IC50 | 6,066 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 22,539,795 | Insulin | P01308.1 | Homo sapiens | v1 | false | false | true | 25 | -51.377 | -42.02092 | -641.383 | -570.21532 | -580.154 | -529.11796 | structures/B4201/G/GPGAGSLQPLAL.silent | -10.357 | 0.92372 |
HLA-B_13_02 | B*13:02 | B1302 | ELPKYGVKV | 9 | Kd | 10,000 | nM | purified MHC/direct/fluorescence | dissociation constant (KD) | 34,290,406 | Large ribosomal subunit protein uL18 | A0A2R8Y4A2.1 | Homo sapiens | v1 | false | false | true | 25 | -72.499 | -60.51392 | -656.959 | -602.89072 | -569.14 | -529.86536 | structures/B1302/E/ELPKYGVKV.silent | -23.549 | -12.51156 |
HLA-B_45_01 | B*45:01 | B4501 | SENERGYYI | 9 | IC50 | 336 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Liver stage antigen 1 | Q25893.1 | Plasmodium falciparum | v1 | false | false | true | 25 | -62.648 | -50.77904 | -631.453 | -596.75332 | -563.413 | -541.4912 | structures/B4501/S/SENERGYYI.silent | -13.809 | -4.48308 |
HLA-B_45_01 | B*45:01 | B4501 | RENANQLVV | 9 | IC50 | 37 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Thrombospondin-related anonymous protein | AAG12328.1 | Plasmodium falciparum | v1 | false | false | true | 25 | -70.503 | -63.96212 | -677.671 | -636.52032 | -594.309 | -558.9796 | structures/B4501/R/RENANQLVV.silent | -17.525 | -13.57844 |
HLA-B_45_01 | B*45:01 | B4501 | NELNYDNAGI | 10 | IC50 | 457 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Circumsporozoite protein | AAA29547.1 | Plasmodium falciparum | v1 | false | false | true | 25 | -58.424 | -48.82304 | -656.17 | -603.75768 | -579.154 | -542.04384 | structures/B4501/N/NELNYDNAGI.silent | -24.168 | -12.89088 |
HLA-B_45_01 | B*45:01 | B4501 | AELLAACF | 8 | IC50 | 247 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Protein P | AAP79852.1 | Hepatitis B virus | v1 | false | false | true | 25 | -71.721 | -61.98296 | -656.432 | -617.99328 | -565.646 | -542.5842 | structures/B4501/A/AELLAACF.silent | -19.527 | -13.42612 |
HLA-B_45_01 | B*45:01 | B4501 | AELLAACFA | 9 | IC50 | 6.6 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Protein P | AAP79852.1 | Hepatitis B virus | v1 | false | false | true | 25 | -65.174 | -57.51288 | -667.107 | -625.21276 | -587.657 | -555.0832 | structures/B4501/A/AELLAACFA.silent | -18.539 | -12.61664 |
HLA-B_45_01 | B*45:01 | B4501 | RETVLEYLV | 9 | IC50 | 205 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Capsid protein | AAO62974.1 | Hepatitis B virus | v1 | false | false | true | 25 | -63.272 | -48.9898 | -637.75 | -553.99684 | -570.839 | -500.47804 | structures/B4501/R/RETVLEYLV.silent | -13.146 | -4.52912 |
HLA-B_45_01 | B*45:01 | B4501 | AEAALENLV | 9 | IC50 | 35 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Genome polyprotein | Q81495.3 | Hepatitis C virus (isolate HCV-K3a/650) | v1 | false | false | true | 25 | -65.15 | -60.055 | -654.594 | -639.74668 | -575.513 | -565.83196 | structures/B4501/A/AEAALENLV.silent | -18.549 | -13.85972 |
HLA-B_45_01 | B*45:01 | B4501 | AENLYVTVF | 9 | IC50 | 69 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | null | ONTIE_0002602 | Human immunodeficiency virus 1 | v1 | false | false | true | 25 | -70.167 | -54.99372 | -665.551 | -591.5246 | -578.537 | -534.19848 | structures/B4501/A/AENLYVTVF.silent | -17.719 | -2.33232 |
HLA-B_45_01 | B*45:01 | B4501 | AENLWVTVYY | 10 | IC50 | 245 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Envelope glycoprotein gp160 | AAA80623.1 | Human immunodeficiency virus 1 | v1 | false | false | true | 25 | -78.41 | -67.28124 | -688.683 | -630.45048 | -591.664 | -552.83576 | structures/B4501/A/AENLWVTVYY.silent | -21.693 | -10.33356 |
HLA-B_45_01 | B*45:01 | B4501 | AENLWVTVY | 9 | IC50 | 68 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 14,634,108 | Envelope glycoprotein gp160 | AAA80623.1 | Human immunodeficiency virus 1 | v1 | false | false | true | 25 | -57.953 | -53.35416 | -630.167 | -598.62044 | -559.054 | -533.89752 | structures/B4501/A/AENLWVTVY.silent | -17.758 | -11.36888 |
HLA-B_45_01 | B*45:01 | B4501 | ADKNLIKCS | 9 | IC50 | 70,000 | nM | cellular MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 19,734,234 | RING finger protein Z | AAQ55253.1 | Mammarenavirus guanaritoense | v1 | false | false | true | 25 | -56.235 | -47.85876 | -639.318 | -591.875 | -574.735 | -543.77528 | structures/B4501/A/ADKNLIKCS.silent | -12.817 | -0.24092 |
HLA-B_45_01 | B*45:01 | B4501 | FEFTSFFY | 8 | IC50 | 12,811 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | v1 | false | false | true | 25 | -67.987 | -62.85524 | -661.351 | -619.0392 | -575.586 | -541.39884 | structures/B4501/F/FEFTSFFY.silent | -21.48 | -14.78524 |
HLA-B_45_01 | B*45:01 | B4501 | FESKSMKL | 8 | IC50 | 53,678 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | v1 | false | false | true | 25 | -62.072 | -57.24244 | -665.447 | -631.56488 | -587.097 | -561.14072 | structures/B4501/F/FESKSMKL.silent | -18.874 | -13.1818 |
HLA-B_45_01 | B*45:01 | B4501 | AEIMKICST | 9 | IC50 | 139 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | AAA43637.1 | Influenza A virus | v1 | false | false | true | 25 | -59.037 | -54.54756 | -650.256 | -623.32172 | -577.642 | -556.3718 | structures/B4501/A/AEIMKICST.silent | -16.053 | -12.4022 |
HLA-B_45_01 | B*45:01 | B4501 | AESRKLLLI | 9 | IC50 | 167 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | v1 | false | false | true | 25 | -69.861 | -60.18236 | -651.649 | -609.46284 | -564.908 | -537.65728 | structures/B4501/A/AESRKLLLI.silent | -18.076 | -11.62332 |
HLA-B_45_01 | B*45:01 | B4501 | CEKLEQSGL | 9 | IC50 | 359 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | RNA-directed RNA polymerase catalytic subunit | P03431.1 | Influenza A virus | v1 | false | false | true | 25 | -65.581 | -50.93512 | -664.875 | -595.67832 | -582.221 | -533.72588 | structures/B4501/C/CEKLEQSGL.silent | -21.638 | -11.01732 |
HLA-B_45_01 | B*45:01 | B4501 | CELTDSSWI | 9 | IC50 | 139 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | v1 | false | false | true | 25 | -63.875 | -55.97244 | -660.736 | -611.82708 | -580.18 | -542.60468 | structures/B4501/C/CELTDSSWI.silent | -20.024 | -13.25008 |
HLA-B_45_01 | B*45:01 | B4501 | AEIEDLIFLA | 10 | IC50 | 8.9 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK18005.1 | Influenza A virus | v1 | false | false | true | 25 | -65.834 | -57.9114 | -637.36 | -596.18384 | -569.83 | -540.26552 | structures/B4501/A/AEIEDLIFLA.silent | -4.638 | 1.99304 |
HLA-B_45_01 | B*45:01 | B4501 | YERMCNILKG | 10 | IC50 | 19,823 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Nucleoprotein | AAK18005.1 | Influenza A virus | v1 | false | false | true | 25 | -71.268 | -57.47764 | -629.788 | -560.96692 | -558.623 | -510.3544 | structures/B4501/Y/YERMCNILKG.silent | 0.103 | 6.865 |
HLA-B_45_01 | B*45:01 | B4501 | AEKPKFLPDLY | 11 | IC50 | 2,929 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | 18,842,709 | Polymerase acidic protein | NP_775531.1 | Influenza A virus | v1 | false | false | true | 25 | -64.325 | -56.31728 | -645.217 | -580.65696 | -564.406 | -515.79184 | structures/B4501/A/AEKPKFLPDLY.silent | -16.486 | -8.54784 |
HLA-B_37_01 | B*37:01 | B3701 | RQSSGSSSSGF | 11 | IC50 | 316.8 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | ATP-dependent RNA helicase DDX3Y | NP_004651.2 | Homo sapiens | v1 | false | false | true | 25 | -62.222 | -51.35524 | -668.415 | -607.52448 | -586.431 | -539.79828 | structures/B3701/R/RQSSGSSSSGF.silent | -22.054 | -16.371 |
HLA-B_37_01 | B*37:01 | B3701 | FQILHDRFF | 9 | IC50 | 365.3 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | v1 | false | false | true | 25 | -79.137 | -70.91544 | -679.728 | -597.74116 | -585.791 | -514.53984 | structures/B3701/F/FQILHDRFF.silent | -18.177 | -12.28592 |
HLA-B_37_01 | B*37:01 | B3701 | TEAEKWPFF | 9 | IC50 | 394.2 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Sex-determining region Y protein (Fragment) | ACQ77096.1 | Tarsius lariang | v1 | false | false | true | 25 | -76.132 | -59.043 | -657.891 | -553.40268 | -566.552 | -486.86872 | structures/B3701/T/TEAEKWPFF.silent | -19.825 | -7.49116 |
HLA-B_37_01 | B*37:01 | B3701 | KVADVDLAVPV | 11 | IC50 | 906.6 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Gamma-taxilin | NP_115965.1 | Homo sapiens | v1 | false | false | true | 25 | -72.068 | -48.65932 | -686.789 | -587.24652 | -589.808 | -532.20048 | structures/B3701/K/KVADVDLAVPV.silent | -24.913 | -6.38668 |
HLA-B_37_01 | B*37:01 | B3701 | IVDCLTEMYY | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | v1 | false | false | true | 25 | -65.815 | -58.61336 | -645.563 | -591.50192 | -566.793 | -523.2168 | structures/B3701/I/IVDCLTEMYY.silent | -16.826 | -9.67176 |
HLA-B_37_01 | B*37:01 | B3701 | ILNRETLLDFV | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Putative gamma-taxilin 2 | AAK13476.1 | Homo sapiens | v1 | false | false | true | 25 | -68.111 | -58.93892 | -653.355 | -585.28032 | -572.504 | -516.44884 | structures/B3701/I/ILNRETLLDFV.silent | -17.735 | -9.89268 |
HLA-B_37_01 | B*37:01 | B3701 | FLLPILSQIYT | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | RNA helicase | XP_001378186.1 | Monodelphis domestica | v1 | false | false | true | 25 | -77.924 | -66.06712 | -647.486 | -577.18072 | -564.344 | -512.06672 | structures/B3701/F/FLLPILSQIYT.silent | -9.442 | 0.953 |
HLA-B_37_01 | B*37:01 | B3701 | SLMASSPTSI | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Lysine-specific demethylase 5D | AAC50806.1 | Homo sapiens | v1 | false | false | true | 25 | -62.566 | -52.085 | -666.767 | -612.32792 | -582.304 | -545.1512 | structures/B3701/S/SLMASSPTSI.silent | -22.693 | -15.09176 |
HLA-B_37_01 | B*37:01 | B3701 | SLLERGQQLGV | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | [histone H3]-trimethyl-L-lysine(4) demethylase | XP_001064297.1 | Rattus norvegicus | v1 | false | false | true | 25 | -62.91 | -54.9784 | -666.785 | -602.51272 | -588.544 | -537.38936 | structures/B3701/S/SLLERGQQLGV.silent | -21.091 | -10.14492 |
HLA-B_37_01 | B*37:01 | B3701 | MIKYCLLKILK | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Histone demethylase UTY | NP_033510.2 | Mus musculus | v1 | false | false | true | 25 | -72.8 | -62.67136 | -663.327 | -613.46608 | -581.791 | -539.77944 | structures/B3701/M/MIKYCLLKILK.silent | -17.774 | -11.01548 |
HLA-B_37_01 | B*37:01 | B3701 | GSSDFQVHFLK | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | v1 | false | false | true | 25 | -57.575 | -51.12988 | -612.849 | -577.37816 | -556.552 | -532.73052 | structures/B3701/G/GSSDFQVHFLK.silent | 0.234 | 6.48224 |
HLA-B_37_01 | B*37:01 | B3701 | YSLEYFQFVKK | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | ubiquitinyl hydrolase 1 | XP_001366553.1 | Monodelphis domestica | v1 | false | false | true | 25 | -55.55 | -43.78076 | -629.132 | -534.21948 | -563.228 | -483.16448 | structures/B3701/Y/YSLEYFQFVKK.silent | -19.476 | -7.27456 |
HLA-B_37_01 | B*37:01 | B3701 | KSLTTTMQFK | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Protocadherin-11 Y-linked | NP_116753.1 | Homo sapiens | v1 | false | false | true | 25 | -68.65 | -55.95528 | -657.886 | -547.51672 | -581.743 | -487.25688 | structures/B3701/K/KSLTTTMQFK.silent | -15.204 | -4.3046 |
HLA-B_37_01 | B*37:01 | B3701 | SYMMDDLELI | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | v1 | false | false | true | 25 | -65.175 | -45.80056 | -599.518 | -537.91676 | -545.016 | -493.8796 | structures/B3701/S/SYMMDDLELI.silent | -7.825 | 1.76344 |
HLA-B_37_01 | B*37:01 | B3701 | YFYYNAFHWAI | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Histone demethylase UTY | AAY16579.1 | Homo sapiens | v1 | false | false | true | 25 | -75.114 | -47.96064 | -672.31 | -529.69892 | -581.115 | -486.819 | structures/B3701/Y/YFYYNAFHWAI.silent | -19.053 | 5.08068 |
HLA-B_37_01 | B*37:01 | B3701 | RYSHWTKL | 8 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Sex-determining region Y protein | P48046.1 | Gorilla gorilla gorilla | v1 | false | false | true | 25 | -71.413 | -64.78216 | -671.131 | -635.7202 | -576.454 | -553.77656 | structures/B3701/R/RYSHWTKL.silent | -23.264 | -17.16152 |
HLA-B_37_01 | B*37:01 | B3701 | SSKMFNYFK | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Isoform 4 of Neuroligin-4, Y-linked | AAH32567.1 | Homo sapiens | v1 | false | false | true | 25 | -68.671 | -60.5686 | -680.193 | -646.37164 | -592.726 | -570.51288 | structures/B3701/S/SSKMFNYFK.silent | -19.165 | -15.29024 |
HLA-B_37_01 | B*37:01 | B3701 | RMILPMSRAFR | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | NP_683745.2 | Mus musculus | v1 | false | false | true | 25 | -70.444 | -59.84712 | -671.17 | -620.41292 | -588.983 | -552.69332 | structures/B3701/R/RMILPMSRAFR.silent | -17.744 | -7.8724 |
HLA-B_37_01 | B*37:01 | B3701 | ELFARSSDPR | 10 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | v1 | false | false | true | 25 | -62.931 | -55.01676 | -660.785 | -622.36884 | -580.406 | -557.77332 | structures/B3701/E/ELFARSSDPR.silent | -21.067 | -9.5788 |
HLA-B_37_01 | B*37:01 | B3701 | LVTMGTGTFGR | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Putative serine/threonine-protein kinase PRKY | O43930.1 | Homo sapiens | v1 | false | false | true | 25 | -53.97 | -44.43336 | -600.562 | -563.80792 | -548.624 | -522.7722 | structures/B3701/L/LVTMGTGTFGR.silent | -5.196 | 3.3976 |
HLA-B_37_01 | B*37:01 | B3701 | LPADPASVL | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Sex-determining region Y protein (Fragment) | ABM65922.1 | Ateles geoffroyi | v1 | false | false | true | 25 | -69.752 | -63.64756 | -692.045 | -661.10712 | -594.867 | -574.02864 | structures/B3701/L/LPADPASVL.silent | -28.151 | -23.43076 |
HLA-B_37_01 | B*37:01 | B3701 | MVRVLTVIKEY | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | CAA73940.1 | Homo sapiens | v1 | false | false | true | 25 | -64.674 | -55.45652 | -615.495 | -565.0086 | -545.741 | -506.33868 | structures/B3701/M/MVRVLTVIKEY.silent | -12.603 | -3.21352 |
HLA-B_37_01 | B*37:01 | B3701 | YQSMIRPPY | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Amelogenin, Y isoform (Fragment) | XP_001145496.1 | Pan troglodytes | v1 | false | false | true | 25 | -62.939 | -50.04824 | -623.539 | -574.887 | -561.749 | -525.18168 | structures/B3701/Y/YQSMIRPPY.silent | -7.841 | 0.34272 |
HLA-B_37_01 | B*37:01 | B3701 | VALFSSCPVAY | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9X | NP_033507.2 | Mus musculus | v1 | false | false | true | 25 | -71.586 | -50.88532 | -556.58 | -458.43712 | -525.542 | -459.35456 | structures/B3701/V/VALFSSCPVAY.silent | 36.347 | 51.803 |
HLA-B_37_01 | B*37:01 | B3701 | FPHTELANL | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Ubiquitin carboxyl-terminal hydrolase 9Y | EAW91607.1 | Homo sapiens | v1 | false | false | true | 25 | -72.132 | -57.74936 | -670.724 | -556.48016 | -579.509 | -486.60604 | structures/B3701/F/FPHTELANL.silent | -22.573 | -12.12484 |
HLA-B_37_01 | B*37:01 | B3701 | LPSCPTNFCIF | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Isoform 2 of Histone demethylase UTY | BAF85547.1 | Homo sapiens | v1 | false | false | true | 25 | -66.455 | -45.78624 | -643.458 | -534.22504 | -572.898 | -488.46552 | structures/B3701/L/LPSCPTNFCIF.silent | -16.345 | 0.02668 |
HLA-B_37_01 | B*37:01 | B3701 | RPPYSSYGY | 9 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Amelogenin, Y isoform (Fragment) | XP_001145496.1 | Pan troglodytes | v1 | false | false | true | 25 | -60.95 | -54.448 | -655.552 | -573.24972 | -578.224 | -500.91216 | structures/B3701/R/RPPYSSYGY.silent | -22.526 | -17.8896 |
HLA-B_37_01 | B*37:01 | B3701 | TFVPIAWAAAY | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Zinc finger protein Y-linked | ACL51661.1 | Callithrix jacchus | v1 | false | false | true | 25 | -71.466 | -60.43368 | -640.65 | -577.1496 | -558.722 | -516.98236 | structures/B3701/T/TFVPIAWAAAY.silent | -10.871 | 0.2666 |
HLA-B_37_01 | B*37:01 | B3701 | LEYFQFVKKLL | 11 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | ubiquitinyl hydrolase 1 | XP_001366553.1 | Monodelphis domestica | v1 | false | false | true | 25 | -69.929 | -59.62724 | -608.538 | -559.42856 | -539.473 | -494.05988 | structures/B3701/L/LEYFQFVKKLL.silent | -19.059 | -5.74156 |
HLA-B_37_01 | B*37:01 | B3701 | YPDPVIKV | 8 | IC50 | 20,000 | nM | purified MHC/competitive/fluorescence | half maximal inhibitory concentration (IC50) | null | Small ribosomal subunit protein eS4, Y isoform 1 | EAX02770.1 | Homo sapiens | v1 | false | false | true | 25 | -69.057 | -61.93628 | -697.151 | -657.31248 | -606.838 | -577.70532 | structures/B3701/Y/YPDPVIKV.silent | -23.108 | -17.67068 |
HLA-B_52_01 | B*52:01 | B5201 | QGFPWDILF | 9 | IC50 | 18 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AAG26087.1 | Hepatitis delta virus | v1 | false | false | true | 25 | -74.48 | -63.53208 | -633.446 | -583.69456 | -548.735 | -509.63252 | structures/B5201/Q/QGFPWDILF.silent | -20.102 | -10.52996 |
HLA-B_52_01 | B*52:01 | B5201 | DRGFPWDILF | 10 | IC50 | 4,682 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AVV65245.1 | Hepatitis delta virus | v1 | false | false | true | 25 | -71.845 | -60.40792 | -631.154 | -573.16772 | -547.616 | -503.21284 | structures/B5201/D/DRGFPWDILF.silent | -19.067 | -9.547 |
HLA-B_52_01 | B*52:01 | B5201 | NQGIPWDILF | 10 | IC50 | 1,469 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | ONTIE_0003412 | Hepatitis delta virus | v1 | false | false | true | 25 | -76.341 | -64.2522 | -648.453 | -577.42328 | -552.953 | -497.4428 | structures/B5201/N/NQGIPWDILF.silent | -25.429 | -15.72844 |
HLA-B_52_01 | B*52:01 | B5201 | QGFPWDMLF | 9 | IC50 | 90 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AAF13849.1 | Hepatitis delta virus | v1 | false | false | true | 25 | -74.167 | -62.51856 | -654.384 | -608.148 | -565.182 | -532.5892 | structures/B5201/Q/QGFPWDMLF.silent | -20.824 | -13.04024 |
HLA-B_52_01 | B*52:01 | B5201 | RGFPWDILF | 9 | IC50 | 224 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AVV65245.1 | Hepatitis delta virus | v1 | false | false | true | 25 | -82.872 | -70.26964 | -669.828 | -624.97324 | -577.686 | -542.45188 | structures/B5201/R/RGFPWDILF.silent | -18.435 | -12.25152 |
HLA-B_52_01 | B*52:01 | B5201 | QGFPWDLLF | 9 | IC50 | 135 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | AAO49188.1 | Hepatitis delta virus | v1 | false | false | true | 25 | -71.632 | -62.08712 | -644.596 | -587.04708 | -557.888 | -513.72808 | structures/B5201/Q/QGFPWDLLF.silent | -20.042 | -11.23188 |
HLA-B_52_01 | B*52:01 | B5201 | SQGFPWDILF | 10 | IC50 | 3,657 | nM | purified MHC/competitive/radioactivity | half maximal inhibitory concentration (IC50) | 30,664,876 | Large delta antigen | P25989.1 | Hepatitis delta virus | v1 | false | false | true | 25 | -70.485 | -59.513 | -634.22 | -570.5102 | -546.067 | -498.17188 | structures/B5201/S/SQGFPWDILF.silent | -22.32 | -12.82552 |
HLA-B_14_02 | B*14:02 | B1402 | MVFGRFSFA | 9 | Kd | 1,178 | nM | purified MHC/direct/fluorescence | dissociation constant (KD) | null | Membrane protein, putative | AAU48420.1 | Burkholderia mallei ATCC 23344 | v1 | false | false | true | 25 | -69.311 | -57.9836 | -648.499 | -606.91628 | -566.687 | -541.4444 | structures/B1402/M/MVFGRFSFA.silent | -16.513 | -7.48844 |
HLA-B_14_02 | B*14:02 | B1402 | FRKAQIQGL | 9 | Kd | 3,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Epstein-Barr nuclear antigen 6 | S33015 | human gammaherpesvirus 4 | v1 | false | false | true | 25 | -75.715 | -61.94064 | -622.512 | -582.84792 | -556.98 | -532.47756 | structures/B1402/F/FRKAQIQGL.silent | 3.021 | 11.5702 |
HLA-B_14_02 | B*14:02 | B1402 | TGIAIIAYI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Lmo2486 protein | CAD00564.1 | Listeria monocytogenes EGD-e | v1 | false | false | true | 25 | -59.166 | -53.26332 | -645.345 | -621.61384 | -570.578 | -557.00676 | structures/B1402/T/TGIAIIAYI.silent | -16.242 | -11.34372 |
HLA-B_14_02 | B*14:02 | B1402 | YLDNVGVHI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Phosphoprotein | AAK55078.1 | Lyssavirus rabies | v1 | false | false | true | 25 | -67.148 | -55.31436 | -682.108 | -595.16484 | -593.277 | -532.3088 | structures/B1402/Y/YLDNVGVHI.silent | -21.683 | -7.5416 |
HLA-B_14_02 | B*14:02 | B1402 | TRAPAPFPL | 9 | Kd | 565 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DNA polymerase III subunit epsilon | AAL59738.1 | Vibrio cholerae | v1 | false | false | true | 25 | -67.844 | -62.19412 | -679.848 | -627.71972 | -586.426 | -542.31012 | structures/B1402/T/TRAPAPFPL.silent | -29.476 | -23.21556 |
HLA-B_14_02 | B*14:02 | B1402 | TTRAVNMEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Gluconate 2-dehydrogenase | AAL53555.1 | Brucella melitensis bv. 1 str. 16M | v1 | false | false | true | 25 | -66.709 | -58.7138 | -635.707 | -611.0774 | -559.67 | -539.51176 | structures/B1402/T/TTRAVNMEV.silent | -17.915 | -12.85168 |
HLA-B_14_02 | B*14:02 | B1402 | KQIVIINPM | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | GlcNAc phosphomutase | AAO10081.1 | Vibrio vulnificus CMCP6 | v1 | false | false | true | 25 | -67.479 | -58.4312 | -688.231 | -632.54028 | -597.603 | -559.2902 | structures/B1402/K/KQIVIINPM.silent | -24.859 | -14.81884 |
HLA-B_14_02 | B*14:02 | B1402 | MYPFIFFIV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Hypothetical membrane spanning protein | AAO90371.1 | Coxiella burnetii RSA 493 | v1 | false | false | true | 25 | -73.881 | -62.122 | -663.03 | -582.06456 | -577.271 | -510.70292 | structures/B1402/M/MYPFIFFIV.silent | -19.423 | -9.23968 |
HLA-B_14_02 | B*14:02 | B1402 | WAIQCYTGV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Na+/H+ antiporter NhaC | AAO07968.1 | Vibrio vulnificus CMCP6 | v1 | false | false | true | 25 | -65.231 | -57.37472 | -645.435 | -594.9872 | -566.022 | -530.05536 | structures/B1402/W/WAIQCYTGV.silent | -15.205 | -7.55728 |
HLA-B_14_02 | B*14:02 | B1402 | ELAPIRVNA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Dehydrogenases with different specificities | BAC97625.1 | Vibrio vulnificus YJ016 | v1 | false | false | true | 25 | -61.822 | -46.2502 | -670.9 | -560.5836 | -592.077 | -507.61656 | structures/B1402/E/ELAPIRVNA.silent | -21.283 | -6.7168 |
HLA-B_14_02 | B*14:02 | B1402 | FTWQHNYYL | 9 | Kd | 20,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | 40S ribosomal protein S10 | EAK87991.1 | Cryptosporidium parvum Iowa II | v1 | false | false | true | 25 | -80.731 | -70.75696 | -687.794 | -623.66684 | -585.847 | -542.85092 | structures/B1402/F/FTWQHNYYL.silent | -21.216 | -10.05904 |
HLA-B_14_02 | B*14:02 | B1402 | NGNFNFERV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glucosidase II subunit alpha | EAK89133.1 | Cryptosporidium parvum Iowa II | v1 | false | false | true | 25 | -70.121 | -59.77908 | -631.297 | -593.594 | -550.607 | -524.95192 | structures/B1402/N/NGNFNFERV.silent | -12.706 | -8.863 |
HLA-B_14_02 | B*14:02 | B1402 | SVFELSNFA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | null | BAC93293.1 | Vibrio vulnificus YJ016 | v1 | false | false | true | 25 | -64.036 | -53.24384 | -637.085 | -561.54484 | -567.053 | -502.47372 | structures/B1402/S/SVFELSNFA.silent | -16.945 | -5.82728 |
HLA-B_14_02 | B*14:02 | B1402 | TVFRNQNRV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Shares a domain with a conserved HREF motif with the CWF15 protein that is involved in mRNA splicing | EAK89397.1 | Cryptosporidium parvum Iowa II | v1 | false | false | true | 25 | -70.937 | -52.80768 | -656.563 | -422.71072 | -572.836 | -367.55036 | structures/B1402/T/TVFRNQNRV.silent | -16.253 | -2.35284 |
HLA-B_14_02 | B*14:02 | B1402 | ERAFQNWSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | DNA topoisomerase | EAL47247.1 | Entamoeba histolytica HM-1:IMSS | v1 | false | false | true | 25 | -66.12 | -52.12504 | -666.357 | -572.55844 | -577.903 | -513.3426 | structures/B1402/E/ERAFQNWSV.silent | -22.334 | -7.0908 |
HLA-B_14_02 | B*14:02 | B1402 | FTLINWRSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | tRNA pseudouridine synthase, putative | EAL50898.1 | Entamoeba histolytica HM-1:IMSS | v1 | false | false | true | 25 | -76.43 | -64.943 | -683.582 | -627.44972 | -585.182 | -550.28072 | structures/B1402/F/FTLINWRSV.silent | -21.971 | -12.22592 |
HLA-B_14_02 | B*14:02 | B1402 | IESNPLFPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Dedicator of cytokinesis protein | EAL49146.1 | Entamoeba histolytica HM-1:IMSS | v1 | false | false | true | 25 | -63.457 | -57.03852 | -668.703 | -624.90664 | -581.624 | -549.94452 | structures/B1402/I/IESNPLFPV.silent | -25.251 | -17.9234 |
HLA-B_14_02 | B*14:02 | B1402 | NPAACSYMV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EAL50926.1 | Entamoeba histolytica HM-1:IMSS | v1 | false | false | true | 25 | -58.039 | -51.36324 | -643.159 | -497.57752 | -572.187 | -437.90416 | structures/B1402/N/NPAACSYMV.silent | -17.466 | -8.30996 |
HLA-B_14_02 | B*14:02 | B1402 | EGAGIDDPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | AcrB/AcrD/AcrF family protein | EAL56425.1 | Campylobacter coli RM2228 | v1 | false | false | true | 25 | -56.493 | -49.61688 | -645.272 | -610.59972 | -578.348 | -551.3372 | structures/B1402/E/EGAGIDDPV.silent | -14.761 | -9.6456 |
HLA-B_14_02 | B*14:02 | B1402 | FFSPFFFSL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Clustered-asparagine-rich protein | CAJ20722.1 | Toxoplasma gondii RH | v1 | false | false | true | 25 | -72.649 | -61.55448 | -652.901 | -552.45 | -569.981 | -487.23292 | structures/B1402/F/FFSPFFFSL.silent | -13.774 | -3.66264 |
HLA-B_14_02 | B*14:02 | B1402 | FMVYVPLPA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Isocitrate dehydrogenase kinase/phosphatase | ABG16349.1 | Yersinia pestis Nepal516 | v1 | false | false | true | 25 | -74.6 | -64.32392 | -695.44 | -618.02012 | -600.191 | -540.19664 | structures/B1402/F/FMVYVPLPA.silent | -22.398 | -13.49964 |
HLA-B_14_02 | B*14:02 | B1402 | YQAENSTAE | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Protein bdm | ABG69490.1 | Escherichia coli 536 | v1 | false | false | true | 25 | -63.58 | -52.1062 | -659.524 | -563.92868 | -581.016 | -498.88632 | structures/B1402/Y/YQAENSTAE.silent | -21.418 | -12.93608 |
HLA-B_14_02 | B*14:02 | B1402 | FGALFMWLL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Cytochrome oxidase subunit | ABF04835.1 | Shigella flexneri 5 str. 8401 | v1 | false | false | true | 25 | -82.326 | -76.42628 | -688.122 | -664.48168 | -584.931 | -567.92088 | structures/B1402/F/FGALFMWLL.silent | -23.582 | -20.1346 |
HLA-B_14_02 | B*14:02 | B1402 | KQIGGTLFE | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glutamate 5-kinase | CAL34268.1 | Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 | v1 | false | false | true | 25 | -61.115 | -51.3944 | -642.62 | -529.70212 | -573.427 | -473.67064 | structures/B1402/K/KQIGGTLFE.silent | -15.717 | -4.63724 |
HLA-B_14_02 | B*14:02 | B1402 | QQRPDLILV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Endonuclease V | CAL22320.1 | Yersinia pestis CO92 | v1 | false | false | true | 25 | -54.798 | -33.762 | -595.538 | -493.959 | -543.51 | -471.84996 | structures/B1402/Q/QQRPDLILV.silent | -6.37 | 11.65304 |
HLA-B_14_02 | B*14:02 | B1402 | GVDGGWQAL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase | ABM49996.1 | Burkholderia mallei SAVP1 | v1 | false | false | true | 25 | -61.466 | -54.89272 | -637.768 | -593.86744 | -569.032 | -530.25024 | structures/B1402/G/GVDGGWQAL.silent | -12.054 | -8.72456 |
HLA-B_14_02 | B*14:02 | B1402 | MGMEQTMSV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | MSHA biogenesis protein MshN | EAX58236.1 | Vibrio cholerae 2740-80 | v1 | false | false | true | 25 | -73.639 | -61.67812 | -659.908 | -611.37396 | -570.395 | -536.4926 | structures/B1402/M/MGMEQTMSV.silent | -20.886 | -13.20332 |
HLA-B_14_02 | B*14:02 | B1402 | NVMDPMHGA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Iron-sulfur cluster-binding protein, rieske family | ABM49342.1 | Burkholderia mallei SAVP1 | v1 | false | false | true | 25 | -73.086 | -64.3278 | -693.06 | -639.89916 | -600.678 | -556.51204 | structures/B1402/N/NVMDPMHGA.silent | -23.624 | -19.05924 |
HLA-B_14_02 | B*14:02 | B1402 | RVACRDVEV | 9 | Kd | 3,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Putative cytochrome P450 140 | CAL71904.1 | Mycobacterium tuberculosis variant bovis BCG str. Pasteur 1173P2 | v1 | false | false | true | 25 | -60.661 | -51.07828 | -646.182 | -586.4138 | -577.677 | -528.16448 | structures/B1402/R/RVACRDVEV.silent | -13.243 | -7.17104 |
HLA-B_14_02 | B*14:02 | B1402 | EGFDPRALI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Glycerophosphoryl diester phosphodiesterase family protein | ABQ60400.1 | Brucella ovis ATCC 25840 | v1 | false | false | true | 25 | -61.735 | -48.36064 | -621.213 | -522.0844 | -562.366 | -481.73144 | structures/B1402/E/EGFDPRALI.silent | -5.346 | 8.00776 |
HLA-B_14_02 | B*14:02 | B1402 | HQFTSNPEV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | FHA domain-containing protein | EDM60245.1 | Vibrio parahaemolyticus AQ3810 | v1 | false | false | true | 25 | -73.445 | -67.16672 | -693.396 | -635.72204 | -598.857 | -546.5586 | structures/B1402/H/HQFTSNPEV.silent | -26.585 | -21.99684 |
HLA-B_14_02 | B*14:02 | B1402 | MTACGRIVV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | TfuA-like core domain-containing protein | EBA41824.1 | Mycobacterium tuberculosis str. Haarlem | v1 | false | false | true | 25 | -69.854 | -63.823 | -655.147 | -586.6378 | -574.499 | -513.52472 | structures/B1402/M/MTACGRIVV.silent | -14.409 | -9.29 |
HLA-B_14_02 | B*14:02 | B1402 | EDFEIFYNL | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Ribonuclease D | ABV79247.1 | Rickettsia bellii OSU 85-389 | v1 | false | false | true | 25 | -71.851 | -62.69236 | -685.804 | -626.39016 | -590.307 | -547.11644 | structures/B1402/E/EDFEIFYNL.silent | -24.616 | -16.58136 |
HLA-B_14_02 | B*14:02 | B1402 | ETVWPFFYA | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Nitrate reductase | ABX61793.1 | Brucella canis ATCC 23365 | v1 | false | false | true | 25 | -65.901 | -59.58956 | -636.175 | -605.00608 | -567.653 | -544.34656 | structures/B1402/E/ETVWPFFYA.silent | -7.541 | -1.06996 |
HLA-B_14_02 | B*14:02 | B1402 | FTARIIIFS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | ABV75419.1 | Rickettsia akari str. Hartford | v1 | false | false | true | 25 | -75.337 | -66.58332 | -670.124 | -575.94348 | -575.874 | -493.35328 | structures/B1402/F/FTARIIIFS.silent | -21.05 | -16.0068 |
HLA-B_14_02 | B*14:02 | B1402 | FVMPIFEQI | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Prophage LambdaBa01, membrane protein | EDR16741.1 | Bacillus anthracis str. A0488 | v1 | false | false | true | 25 | -81.906 | -72.99944 | -685.454 | -649.78848 | -583.321 | -560.90872 | structures/B1402/F/FVMPIFEQI.silent | -22.337 | -15.8804 |
HLA-B_14_02 | B*14:02 | B1402 | MTFPLHFRS | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO77069.1 | Giardia lamblia ATCC 50803 | v1 | false | false | true | 25 | -68.042 | -62.02836 | -681.225 | -639.79876 | -595.791 | -562.99972 | structures/B1402/M/MTFPLHFRS.silent | -21.079 | -14.77076 |
HLA-B_14_02 | B*14:02 | B1402 | MTYLDGHPV | 9 | Kd | 5,000 | nM | purified MHC/competitive/fluorescence | dissociation constant (KD) | null | Uncharacterized protein | EDO78551.1 | Giardia lamblia ATCC 50803 | v1 | false | false | true | 25 | -76.937 | -69.27808 | -704.778 | -663.0394 | -599.185 | -572.5628 | structures/B1402/M/MTYLDGHPV.silent | -30.118 | -21.19864 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.